[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/main/docs/Risk/index.md) >> Individual ID:PBN__Risk_1359 

# __Absence of efficacy studies in clinical settings__

## Category to which it belongs

* [The challenges in the field of testing and drug development, including limited capacity, slow processes, and the need for improved detection methods, hamper the identification and control of cases.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_134.md)

## Closest similar item

* [Limited data, efficacy](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2954.md)
* [Ineffective non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1478.md)
* [Insufficient non-pharmaceutical interventions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1590.md)
* [Lack of effective treatment](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1849.md)
* [Lack of drug therapy options](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1139.md)
* [Risk of waning efficacy](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_3122.md)
* [Amplification of flawed trial data in meta-analyses](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_618.md)
* [Poor compliance with interventions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1529.md)
* [Lack of adherence to prevention measures](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_2356.md)
* [Inconsistent implementation of interventions](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_1385.md)

## Description of the risk

Limited research and data on the effectiveness of upper-room UV lights and negative air ionization in preventing TB transmission in healthcare settings

## Is the risk affecting GBN scales

* [Yes](https://github.com/mm80843/T3.5/blob/main/docs/RiskGBN/PBN__RiskGBN_1.md)

## Type of the risk

* [Other](https://github.com/mm80843/T3.5/blob/main/docs/RiskHealth/PBN__RiskHealth_2.md)

## Type of impact of the risk (according to ISO37100)

* [Health and care](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Purpose_0.md)

## Type of purpose of the risk (according to ISO37100)

* [Responsible resource use](https://github.com/mm80843/T3.5/blob/main/docs/RiskISO/PBN__RiskISO_Impact_4.md)

## Mitigations of this risk

* [Conduct more efficacy studies in clinical settings to evaluate the impact of these measures on tb transmission](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1860.md)

## Name of the risk

Uncertainty about the effectiveness of these measures in real-world conditions

## Stakeholders who can mitigate this risk

* [Researchers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_2.md)
* [Healthcare facilities](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_33.md)

## Articles mentionning the risk

* [Upper-Room Ultraviolet Light and Negative Air Ionization to Prevent Tuberculosis Transmission](https://github.com/mm80843/T3.5/blob/main/docs/Article/PBN__Article_105.md)

## People affected by this risk

* [Healthcare workers](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_68.md)
* [Patients](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_31.md)
* [Visitors](https://github.com/mm80843/T3.5/blob/main/docs/Stakeholder/PBN__Stakeholder_118.md)

## Technologies linked to the risk

* [Nan](https://github.com/mm80843/T3.5/blob/main/docs/Technology/PBN__Technology_22.md)

## Property: has_RiskType

* [Technological](https://github.com/mm80843/T3.5/blob/main/docs/RiskType/PBN__RiskType_5.md)

